These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 17916770)

  • 41. Factors IX, XI, and XII: potential therapeutic targets for anticoagulant therapy in atherothrombosis.
    Rai V; Balters MW; Agrawal DK
    Rev Cardiovasc Med; 2019 Dec; 20(4):245-253. PubMed ID: 31912715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial Surfaces.
    Tillman B; Gailani D
    Semin Thromb Hemost; 2018 Feb; 44(1):60-69. PubMed ID: 28898903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
    Mackman N; Tilley RE; Key NS
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roles of platelets and factor XI in the initiation of blood coagulation by thrombin.
    Walsh PN
    Thromb Haemost; 2001 Jul; 86(1):75-82. PubMed ID: 11487044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.
    Tucker EI; Marzec UM; White TC; Hurst S; Rugonyi S; McCarty OJ; Gailani D; Gruber A; Hanson SR
    Blood; 2009 Jan; 113(4):936-44. PubMed ID: 18945968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
    Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
    Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Coagulation factor XII deficiency, a contribution to thrombophilia].
    Klare M
    Z Gesamte Inn Med; 1984 Nov; 39(22):562-4. PubMed ID: 6528678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The intravascular generation of fibrinogen derivatives and the blood vessel wall in venous thrombosis and disseminated intravascular coagulation.
    Stewart GJ
    Thromb Haemost; 1977 Dec; 38(4):831-49. PubMed ID: 146274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model.
    van Montfoort ML; Knaup VL; Marquart JA; Bakhtiari K; Castellino FJ; Hack CE; Meijers JC
    Thromb Haemost; 2013 Nov; 110(5):1065-73. PubMed ID: 23925504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
    Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
    Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factor XI and protection of the fibrin clot against lysis--a role for the intrinsic pathway of coagulation in fibrinolysis.
    Bouma BN; von dem Borne PA; Meijers JC
    Thromb Haemost; 1998 Jul; 80(1):24-7. PubMed ID: 9684779
    [No Abstract]   [Full Text] [Related]  

  • 52. Blood coagulation factor XII--a neglected player in stroke pathophysiology.
    Pham M; Stoll G; Nieswandt B; Bendszus M; Kleinschnitz C
    J Mol Med (Berl); 2012 Feb; 90(2):119-26. PubMed ID: 21909687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.
    Spronk HMH; Padro T; Siland JE; Prochaska JH; Winters J; van der Wal AC; Posthuma JJ; Lowe G; d'Alessandro E; Wenzel P; Coenen DM; Reitsma PH; Ruf W; van Gorp RH; Koenen RR; Vajen T; Alshaikh NA; Wolberg AS; Macrae FL; Asquith N; Heemskerk J; Heinzmann A; Moorlag M; Mackman N; van der Meijden P; Meijers JCM; Heestermans M; Renné T; Dólleman S; Chayouâ W; Ariëns RAS; Baaten CC; Nagy M; Kuliopulos A; Posma JJ; Harrison P; Vries MJ; Crijns HJGM; Dudink EAMP; Buller HR; Henskens YMC; Själander A; Zwaveling S; Erküner O; Eikelboom JW; Gulpen A; Peeters FECM; Douxfils J; Olie RH; Baglin T; Leader A; Schotten U; Scaf B; van Beusekom HMM; Mosnier LO; van der Vorm L; Declerck P; Visser M; Dippel DWJ; Strijbis VJ; Pertiwi K; Ten Cate-Hoek AJ; Ten Cate H
    Thromb Haemost; 2018 Feb; 118(2):229-250. PubMed ID: 29378352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the contact pathway in thrombus propagation.
    Gruber A
    Thromb Res; 2014 May; 133 Suppl 1():S45-7. PubMed ID: 24759142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.
    Nickel KF; Labberton L; Long AT; Langer F; Fuchs TA; Stavrou EX; Butler LM; Renné T
    Thromb Res; 2016 May; 141 Suppl 2():S4-7. PubMed ID: 27207422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available.
    Wielders SJ; Béguin S; Hemker HC; Lindhout T
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1138-42. PubMed ID: 15072993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New agents for thromboprotection. A role for factor XII and XIIa inhibition.
    Labberton L; Kenne E; Renné T
    Hamostaseologie; 2015; 35(4):338-50. PubMed ID: 25609114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factor XI as a Therapeutic Target.
    Gailani D; Gruber A
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1316-22. PubMed ID: 27174099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.